Aegerion Pharmaceuticals Cash from Financing Quarterly
Aegerion Pharmaceuticals Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.1816M |
| Sept. 30, 2012 | 6.054M |
| June 30, 2012 | 47.61M |
| March 31, 2012 | -0.4623M |
| Dec. 31, 2011 | 0.005M |
| Sept. 30, 2011 | 1.789M |
| June 30, 2011 | 47.73M |
| March 31, 2011 | 9.810M |
| Dec. 31, 2010 | 47.68M |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
AEGR Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Isis Pharmaceuticals | 9.05M |
| Sanofi | |
| Keryx Biopharmaceuticals | 0.00 |
AEGR Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -0.6657M | Jun 2009 |
| Maximum | 47.73M | Jun 2011 |
| Average | 11.92M |